Orencia clickject 125 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26F1AV8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,876
Award facts
- Contract value 100% obligated
- $44,875.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,875.61 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 28, 2026, for the supply of Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract has an ultimate completion date of January 29, 2026, and was awarded on a competitive basis with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery order is executed under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
Amerisourcebergen Drug Corp serves as a critical vendor within the federal pharmaceutical supply chain, routinely fulfilling orders for specialty medications, vaccines, and medical devices across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs. The company's extensive portfolio of DLA contract awards demonstrates its capability to efficiently manage both small-value transactions and substantial orders, positioning it as a key provider within the Defense Health Agency's medical supply infrastructure. The competitive award of this delivery order reflects Amerisourcebergen's ability to meet federal procurement requirements for specialized biologic therapies essential to military personnel healthcare.
Quick answers
Who was awarded contract SPE2DR26F1AV8?
SPE2DR26F1AV8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F1AV8 worth?
The government has obligated $44,876 on SPE2DR26F1AV8.
Is contract SPE2DR26F1AV8 an order under another contract?
Yes. SPE2DR26F1AV8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AV8 competed?
The extent of competition for SPE2DR26F1AV8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award